Latest

Alzheimer’s disease

·August 30, 2012·3 min read

New Diagnostic Biomarkers Offer Ray of Hope for Alzheimer’s Disease

Investigators report on the development of imaging-based biomarkers that will have an impact on diagnosis before the Alzheimer's disease process is set in motion.

Featured Neurology

·August 20, 2012·2 min read

Brain Enzyme is Double Whammy for Alzheimer’s Disease

Researchers discover that an enzyme known for generating toxic brain plaques in Alzheimer's disease also causes additional memory and cognitive deficits via a separate mechanism. They found that BACE1 disrupts the cell's production of other molecules required for PKA function. By that mechanism, BACE1 inactivates PKA and therefore inhibits memory formation in mice, even in the absence of neurotoxic β-amyloid.

Featured Neurology Neuroscience Neuroscience Videos

·August 15, 2012·5 min read

Scientists Discover Previously Unknown Cleansing System in Brain

A previously unrecognized system that drains waste from the brain at a rapid clip has been discovered by neuroscientists at the University of Rochester Medical Center and dubbed the glymphatic system.

Featured Neurology

·August 9, 2012·3 min read

Blood Test for Alzheimer’s Gaining Ground

Scientists have taken a step toward developing a blood test for Alzheimer's, finding a group of markers that hold up in statistical analyses in three independent groups of patients.

Featured Neurology

·August 1, 2012·2 min read

Artificial Butter Flavoring Ingredient Linked to Key Alzheimer’s Disease Process

A new study raises concern about chronic exposure of workers in industry to a food flavoring ingredient used to produce the distinctive buttery flavor and aroma of microwave popcorn, margarines, snack foods, candy, baked goods, pet foods and other products. It found evidence that the ingredient, diacetyl (DA), intensifies the damaging effects of an abnormal brain protein linked to Alzheimer’s disease.

Featured Neurology

·July 24, 2012·4 min read

New Research Determines How a Single Brain Trauma May Lead to Alzheimer’s Disease

A study, performed in mice and utilizing post-mortem samples of brains from patients with Alzheimer’s disease, found that a single event of a moderate-to-severe traumatic brain injury (TBI) can disrupt proteins that regulate an enzyme associated with Alzheimer’s. The paper, published in The Journal of Neuroscience, identifies the complex mechanisms that result in a rapid and robust post-injury elevation of the enzyme, BACE1, in the brain. These results may lead to the development of a drug treatment that targets this mechanism to slow the progression of Alzheimer’s disease.

Neurology Neuroscience Business

·July 19, 2012·2 min read

Anti-Tau Drug Improves Cognition, Decreases Tau Tangles in Alzheimer’s Disease Models

Penn Medicine research presented today at the 2012 Alzheimer's Association International Conference shows that an anti-tau treatment called epithilone D (EpoD) was effective in preventing and intervening the progress of Alzheimer's disease in animal models, improving neuron function and cognition, as well as decreasing tau pathology.

Featured Genetics Neurology

·July 11, 2012·3 min read

Two Proteins Offer a Clearer Way to Treat Huntington’s Disease

HD mice crossbred with mice that produced greater levels of PGC-1alpha showed dramatic improvement. Production of misfolded proteins was essentially eliminated and the mice behaved normally. “Degeneration of brain cells is prevented. Neurons don’t die,” said La Spada.

Featured Neurology Neuroscience Business

·July 10, 2012·4 min read

Nutrient Mixture Improves Memory in Patients with Early Alzheimer’s

A clinical trial of an Alzheimer’s disease treatment developed found that the nutrient cocktail can improve memory in patients with early Alzheimer’s. The mixture appears to increase the number of dendritic spines and therefore some synapses.